前收市價 | 25.64 |
開市 | 25.65 |
買盤 | 25.62 x 3100 |
賣出價 | 25.63 x 3200 |
今日波幅 | 25.58 - 25.83 |
52 週波幅 | 25.20 - 40.37 |
成交量 | |
平均成交量 | 41,139,283 |
市值 | 145.188B |
Beta 值 (5 年,每月) | 0.57 |
市盈率 (最近 12 個月) | 69.30 |
每股盈利 (最近 12 個月) | 0.37 |
業績公佈日 | 2024年5月01日 |
遠期股息及收益率 | 1.68 (6.55%) |
除息日 | 2024年5月09日 |
1 年預測目標價 | 29.05 |
On BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its pipeline development now that the pandemic is over.
Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.
Lilly (LLY) delivered earnings and revenue surprises of 1.98% and 0.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?